Saturday, 6 Jun 2020
SQU gets patent for new gangrene treatment

SQU gets patent for new gangrene therapy

Dr Sidgi Syed Anwar Abdo Hasson and Prof Ali Abdullah Hassan al Jabri from the Department of Microbiology and Immunology, College of Medicine &amp Health Sciences, SQU worked on the invention.

The patent application was filed final year with the United States Patent and Trademark Office. The invention relates to therapy of dry and wet gangrene, and specifically to a approach of creating a therapeutic tropical plants and camel items-primarily based composition for the therapy of gangrene.

Commenting on their function, the inventors mentioned that it is a scientific breakthrough that resulted from numerous years of continuous function involving a wide variety of scientific analysis disciplines. It relates to a novel therapy for dry and wet gangrene.

Gangrene is a situation in which a loss of blood provide causes physique tissue to die. It can impact any component of the physique but usually begins in the toes, feet, fingers and hands.

“The management of gangrene differs according to whether it is sterile/aseptic (dry) or infected/septic (wet). Surgical removal of dead tissue and amputation are usually reserved for septic wet gangrene as a result of infection in immune-compromised patients with diabetes,” they mentioned.

Despite efficacious anti-microbial therapy and enhanced supportive measures, ‘wet’ gangrene therapy nonetheless poses immense challenges and is generally regarded as ‘incurable’. “Although various therapies for the treatment are available, however, such therapies are quite often, unable to treat wounds leading to amputation of the infected limbs. Thus, a therapy for wet and dry gangrene solving the aforementioned problems is desired.”

Although it is in its preliminary clinical trial, this new formula could potentially be purposed

as a therapy for wet and dry gangrene, according to encouraging information from the pre-clinical trial.

The drug formula composition consists of 3 components: a mixture of 3 extracts of tropical herbs, camel milk and camel saliva. The milk is harvested from a camel that is fed the herbal composition mixed with camel saliva at sufficient concentration. “The therapeutic composition was found to regenerate damaged tissue as well as bone marrow stem cells in both animals and humans. The composition is effective in curing non-healing wounds of diabetics and ‘wet’ gangrene,” they mentioned.

The therapeutic composition can also be employed to treat wounds, skin ulcers, necrosis and burns. It can be administered each orally and topically.

“The composition exhibits remarkable efficacy in treating and curing acute ‘wet’ gangrene, which is generally regarded as ‘incurable’ and mostly requires limb amputation. The novel strategy of using camel as a manufacturer vehicle could open research gates for other clinical complications treatments,” the inventors mentioned.

Information Source: Muscat Daily

Check Also

Around 3,800 school students to benefit from first 3D mobile lab – Oman

The principal objective of this project is to teach and inspire school students from across …